Examkin

Soru

Zorluk: ZorBreast Disorders

A 49-year-old woman is evaluated in the surgical oncology clinic due to rapid changes in her right breast over the past five weeks. She was initially treated at an urgent care clinic with a two-week course of oral clindamycin for presumed cellulitis, but the condition has progressively worsened. She has no personal or family history of breast malignancy and previously had normal screening mammograms. Vital signs are normal. Examination of the right breast reveals diffuse enlargement, marked erythema, and increased warmth. The skin demonstrates prominent pitting edema encompassing most of the breast surface. Palpation reveals diffuse, firm tissue thickening without a discrete localized lump. Hard, enlarged lymph nodes are palpable in the right axillary region.

Arrange the following clinical interventions in the most appropriate chronological order for the diagnosis, staging, and definitive management of this patient.

  1. 1Bilateral diagnostic mammography and targeted ultrasonography
  2. 2Image-guided core needle biopsy of the breast and skin punch biopsy
  3. 3Systemic staging with cross-sectional imaging and bone scintigraphy
  4. 4Induction of systemic neoadjuvant chemotherapy
  5. 5Modified radical mastectomy and axillary lymph node dissection

Cevap

The correct sequence of interventions is: 1) Bilateral diagnostic mammography and targeted ultrasonography, 2) Image-guided core needle biopsy of the breast and skin punch biopsy, 3) Systemic staging with cross-sectional imaging and bone scintigraphy, 4) Induction of systemic neoadjuvant chemotherapy, and finally 5) Modified radical mastectomy and axillary lymph node dissection.
The diagnosis and management of inflammatory breast cancer (IBC) require a multidisciplinary approach executed in a specific sequence. When a patient presents with classic signs of IBC (erythema, edema, peau d'orange) that do not respond to antibiotics, the first step is diagnostic imaging (mammography and ultrasound) to evaluate the breast and axilla. This is immediately followed by tissue diagnosis via core needle biopsy of the breast parenchyma and a punch biopsy of the affected skin to confirm dermal lymphatic invasion. Because IBC is inherently a locally advanced disease (Stage IIIB or IIIC) with a high propensity for early metastasis, complete systemic staging (e.g., CT chest/abdomen/pelvis and bone scan) must be performed next. Once distant metastasis is ruled out, the patient must receive systemic neoadjuvant chemotherapy as the initial treatment modality. Upfront surgery is strictly contraindicated due to the high likelihood of positive surgical margins and the need to promptly address micrometastatic spread. Following a clinical response to neoadjuvant chemotherapy, the patient undergoes a modified radical mastectomy (breast-conserving surgery is contraindicated in IBC), typically followed by postmastectomy radiation therapy.

Adım Adım Çözüm

1
Recognize the clinical presentation as highly suspicious for Inflammatory Breast Cancer (IBC).
Identify the need for an urgent oncologic workup rather than further antibiotic therapy.
The patient has progressive breast erythema, edema, and peau d'orange that did not respond to antibiotics, which are classic signs of IBC.
2
Order bilateral diagnostic mammography and targeted ultrasonography.
Evaluate the extent of the local disease and identify regional lymph node involvement.
Imaging is the necessary first step to characterize the breast tissue, assess for underlying masses or calcifications, and guide subsequent biopsy targets.
3
Perform image-guided core needle biopsy of the breast and skin punch biopsy.
Obtain histologic confirmation of invasive carcinoma and dermal lymphatic tumor emboli.
A definitive tissue diagnosis is required before any oncologic therapy can be initiated. A skin punch biopsy specifically evaluates for dermal lymphatic invasion characteristic of IBC.
4
Order systemic staging (CT of the chest, abdomen, pelvis, and bone scan, or PET/CT).
Determine the presence or absence of distant metastatic disease.
IBC is categorized as locally advanced (Stage III) at a minimum and carries a high risk of occult distant metastasis at presentation. Staging must precede treatment because Stage IV disease significantly alters the management goals.
5
Administer neoadjuvant chemotherapy.
Reduce the local tumor burden, clear skin involvement, and treat potential micrometastatic disease.
Upfront systemic therapy is the standard of care for non-metastatic IBC to improve surgical outcomes and overall survival.
6
Perform modified radical mastectomy with axillary lymph node dissection.
Achieve definitive local surgical control.
Breast-conserving therapy (lumpectomy) is contraindicated in IBC due to the diffuse nature of the disease and unacceptably high recurrence rates. Mastectomy follows chemotherapy.

Anahtar Kavram

The diagnostic and management pathway for Inflammatory Breast Cancer follows a strict sequence: Imaging -> Biopsy -> Systemic Staging -> Neoadjuvant Chemotherapy -> Mastectomy -> Postmastectomy Radiation.
Bu soruyu puanla

Konular

Breast Disorders

Bu konudan daha fazla soru